Vitamin K2 and Reduced Undercarboxylated Osteocalcin Level

• Vitamin K₂ therapy for postmenopausal osteoporosis.

  • 2014-05-16
  • Review
  • Nutrients 6(5)
  • • Jun Iwamoto

  • PubMed: 24841104
  • DOI: 10.3390/nu6051971

  4 Insights on

  • Reduced Undercarboxylated Osteocalcin Level

  • Moderate evidence
  • Rigorous Journal
  • Clinical

  Small RCTs showed that menatetrenone monotherapy decreased serum undercarboxylated osteocalcin (ucOC) concentrations

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes